Reformulated OxyContin led to spike in Hepatitis C infections
February 5, 2019Manufacturing and Production OxyContin, USA, hepatitis C, heroin, infectious diseases, opioids
Efforts to create an “abuse deterrent” OxyContin pill inadvertently led to an increase in the number of Hepatitis C infections, …
Sanders calls on Catalyst pharma to justify $375,000 price tag for rare disease drug which was once free
February 5, 2019Manufacturing and Production Catalyst Pharmaceuticals, Jacobus Pharmaceuticals, Sanders, USA, pharma, pricing
Shares in Catalyst Pharmaceuticals plummeted Monday, after US Senator Bernie Sanders sent the firm a letter asking them to justify …
Alexander Hardy returns to Genentech as new CEO
February 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, appointment, pharma
Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
Positive CHMP recommendation for Sanofi’s atherosclerotic CVD drug Praluent
February 4, 2019Sales and Marketing Europe, atherosclerotic cardiovascular disease, cvd, pharma, praluent
It has been announced that Sanofi’s Praluent (alirocumab) has been awarded a positive recommendation from the European Medicines Agency’s Committee …
Counterfeit drugs – countering the lies
February 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent
As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …
100,000 extra GP appointments to be made available in Gloucestershire as part of NHS Long Term Plan
February 4, 2019Sales and Marketing GP, Gloucestershire, NHS, UK, britain, primare care
GP practices in Gloucestershire are set to offer 100,000 more appointments for patients in the coming year. The initiative comes …
FDA knocks back Alkermes’ opioid-based depression therapy over lack of evidence
February 4, 2019Sales and Marketing Alkermes, FDA, major depressive disorder, pharma, rejection
Alkermes experimental opioid-based depression therapy ALKS 5461 has been rejected by the FDA, it has emerged, in the adjunctive treatment …
Cambridgeshire and Peterborough NHS Foundation Trust launches mental health clinical trials
February 4, 2019Sales and Marketing UK, clinical trials, clozapine, mental health, schizophrenia
The Cambridgeshire and Peterborough NHS Foundation Trust’s Windsor Research Unit is offering patients the chance to participate in clinical trials …
Obesity-related cancers on the rise amongst millennials
February 4, 2019Sales and Marketing Cancer, obesity, oncology, young people
Cancers related to obesity are on the rise in young adults, according to findings from the American Cancer Society, published …
Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx
February 1, 2019Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma
In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …
Top Ten most popular articles on Pharmafile.com this week!
February 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10
Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …
Health officials declare state of emergency in Washington after 36 confirmed cases of measles
February 1, 2019Medical Communications MMR, Seattle, measles, oregon, portland, vaccines, washington
Health officials have declared a state of emergency in Washington as an outbreak of measles continues to spread. As January …
Novartis’ CAR-T therapy Kymriah gets NICE green light in diffuse large B-cell lymphoma
February 1, 2019Medical Communications, Sales and Marketing CAR-T, Cancer, Kymriah, NICE, Novartis, lymphoma, pharma
NICE has announced another momentous decision for lymphoma patients in England and Wales:, recommending Novartis’ chimeric antigen receptor T cell …
400 Pfizer employees set to strike over pensions
February 1, 2019Medical Communications EU, Ireland, Little Island, Pfizer, Ringaskiddy, SITPU, strike
400 Pfizer employees are set to go on strike in Ireland over an ongoing pensions dispute. Members of SITPU, Ireland’s …
Repurposed drugs: The Supreme Court deals a blow to patentees
January 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma
Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …
Stripper-turned-Insys sales rep gave lap dance to persuade doctor to prescribe fentanyl
January 31, 2019Medical Communications Sunrise Lee, US, chicago, corruption, insys, sales
A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort …
Janssen’s Erleada meets primary endpoints in ongoing trial into metastatic castration-sensitive prostate cancer
January 31, 2019Research and Development Cancer, Erleada, Janssen, pharma, prostate cancer
Janssen has revealed that its androgen receptor (AR) inhibitor Erleada (apalutamide), in combination with androgen deprivation therapy (ADT), has been …
Mylan’s Wixela becomes first FDA-approved generic version of GSK’s Advair inhaler
January 31, 2019Sales and Marketing Advair, COPD, FDA, Wixela, asthma, generic, pharma
Mylan’s Wixela has become the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler to …
Purdue Pharma sought to expand into opioid addiction treatments while using McKinsey to counter “emotional messages”
January 31, 2019Business Services, Medical Communications Massachusetts, OxyContin, Purdue Pharma, US, USA, opioids
OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents that …
Health Secretary pledges to end transmission of HIV in England by 2030
January 31, 2019Medical Communications, Research and Development 2030, AIDS, England, HIV, UN, health
Through better prevention, detection and treatment, Health Secretary Matt Hancock has pledged to end transmission of HIV in England by …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
